Abstract
Inflammasomes can be a potential target for the management of chronic inflammatory disease including lung disorders using advanced delivery systems. Pulmonary diseases are a broad category of acute and chronic disease related to the lungs. These diseases primarily include asthma, acute lung injury, chronic obstructive pulmonary disease, pulmonary hypertension, pulmonary fibrosis and lung cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 2407-2410 |
| Number of pages | 4 |
| Journal | Nanomedicine |
| Volume | 16 |
| Issue number | 27 |
| DOIs | |
| Publication status | Published - Nov 2021 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- drug delivery
- inflammasomes
- pulmonary
Fingerprint
Dive into the research topics of 'Applications of drug-delivery systems targeting inflammasomes in pulmonary diseases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver